Advancing Next Generation Radioligand Candidates to Commercialisation Through Rigorous Clinical Rationale, Novel Target Selection & Reliable Supply Chain Design
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2024 event, please get in touch at info@hansonwade.com
Welcome to the Targeted Radiopharmaceuticals Manufacturing and Supply Chain Summit 2023
The biggest challenges facing targeted radiopharmaceuticals are the highly complex processes associated with acquiring raw radioisotope APIs, the limited availability of these radionuclides, and getting whole-drug products to patients on time. This can’t be done alone! Abdera, Clarity, and Rayze have all recently landed landmark supply deals to fuel their clinical development and there are certainly more to come!
The Targeted Radiopharmaceuticals Manufacturing and Supply Chain Summit 2023 was the only industry-led meeting dedicated to plugging the gaps in radioisotope supply by developing new sources, designing manufacturing facilities that are scalable, and ensuring safety and quality through well-tested release criteria for whole drug products.
You missed the union of 80+ key stakeholders in CMC, quality assurance, operations, facility managers, and radiopharmacists to bring the targeted radiotherapies to the forefront of cancer treatment.
Capitalizing on the recent successes this space had over 2023, there has never been this amount of demand and excitement for the TRP community. Our audience took advantage of this platform to hear in-depth challenges and solutions in the global TRP manufacturing landscape.
Top 5 Benefits of Attending:
Establish more reliable supply chains to meet the needs of patients and the expectations of clinicians every time by implementing next-generation ordering systems, tracking technology and optimized processes with Bayer
Overcome stock issues of Lutetium and Actinium by taking advantage of the potential novel isotopes has, including Copper, Lead, Astatine, and Terbium with Convergent Therapeutics
Enhance the efficiency at your current sites, or scale up by learning from those that have led the way in GMP radiopharmaceutical manufacturing with Fusion Pharmaceuticals
Guarantee quality by updating your quality control release criteria with the most up-to-date information for a variety of isotopes, chelators and targeting systems with Radiomedix
Avoid making costly mistakes by ensuring you are up to date with rapidly changing regulations for isotopes, antibodies and whole drug products to avoid being slowed down with Earli
Your 2023 Expert Speakers Included:
2023 Partners:
